Ирландия - английский - HPRA (Health Products Regulatory Authority)

pco manufacturing - fluoxetine hydrochloride - capsules - 20mg - adults major depressive episodes obsessive compulsive disorder bulimia nervosa:prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity

Ирландия - английский - HPRA (Health Products Regulatory Authority)

pco manufacturing - fluoxetine hydrochloride - capsules - 20mg - adults major depressive episodes obsessive compulsive disorder bulimia nervosa:prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity

Ирландия - английский - HPRA (Health Products Regulatory Authority)

pco manufacturing - fluoxetine hydrochloride - capsules - 20mg - adults major depressive episodes obsessive compulsive disorder bulimia nervosa:prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity

Ирландия - английский - HPRA (Health Products Regulatory Authority)

pco manufacturing - fluoxetine hydrochloride - capsules - 20mg - adults major depressive episodes obsessive compulsive disorder bulimia nervosa:prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity

Ирландия - английский - HPRA (Health Products Regulatory Authority)

dista products limited - fluoxetine hydrochloride - tablets - 20mg - adults major depressive episodes obsessive compulsive disorder bulimia nervosa:prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity

Ирландия - английский - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - fluoxetine hydrochloride - capsules gastro-resistant - 90mg - adults major depressive episodes obsessive compulsive disorder bulimia nervosa:prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity

Австралия - английский - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - fluoxetine hydrochloride - capsules and tablets - 20 mg of fluoxetine as the active ingredient - prozac is indicated for the treatment of: major depression. obsessive compulsive disorder. premenstrual dysphoric disorder (pmdd)

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg - capsule - 20 mg - active: fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg excipient: dimeticone gelatin ink iron oxide yellow patent blue v starch titanium dioxide - · depression and it's associated anxiety · bulimia nervosa · obsessive-compulsive disorder and premenstrual dysphoric disorder - a severe form of pms. diagnosis of pmdd: the essential features of pmdd are clear and established cyclicity of symptoms (occurring during the last week of the luteal phase in most menstrual cycles) such as depressed mood, anxiety, affective lability, and physical symptoms such as breast tenderness or swelling, headaches, joint or muscle pain, bloating, and weight gain. pmdd is a severe clinical entity and is distinguished from the broader premenstrual syndrome by the intensity of its symptoms (particularly mood symptoms) and the extent to which it interferes with social and/or occupational function

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg - dispersible tablet - 20 mg - active: fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg excipient: aniseed colloidal silicon dioxide crospovidone mannitol mentha x piperita microcrystalline cellulose saccharin sodium sodium stearyl fumarate sorbitol starch - depression and it's associated anxiety, bulimia nervosa, obsessive-compulsive disorder and premenstrual dysphoric disorder - a severe form of pms. diagnosis of pmdd: the essential features of pmdd are clear and established cyclicity of symptoms (occurring during the last week of the luteal phase in most menstrual cycles) such as depressed mood, anxiety, affective lability, and physical symptoms such as breast tenderness or swelling, headaches, joint or muscle pain, bloating, and weight gain. pmdd is a severe clinical entity and is distinguished from the broader premenstrual syndrome by the intensity of its symptoms (particularly mood symptoms) and the extent to which it interferes with social and/or occupational function

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - fluoxetine hydrochloride 75.75mg equivalent to fluoxetine 60 mg - capsule - 60 mg - active: fluoxetine hydrochloride 75.75mg equivalent to fluoxetine 60 mg - depression and it's associated anxiety, bulimia nervosa, obsessive-compulsive disorder and premenstrual dysphoric disorder - a severe form of pms. diagnosis of pmdd: the essential features of pmdd are clear and established cyclicity of symptoms (occurring during the last week of the luteal phase in most menstrual cycles) such as depressed mood, anxiety, affective lability, and physical symptoms such as breast tenderness or swelling, headaches, joint or muscle pain, bloating, and weight gain. pmdd is a severe clinical entity and is distinguished from the broader premenstrual syndrome by the intensity of its symptoms (particularly mood symptoms) and the extent to which it interferes with social and/or occupational function